Postoperative Pain Management in Rhinoplasty
Trial ID or NCT#
Status
Purpose
The primary purpose of the study is to determine adequacy of postoperative pain control after nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess the degree of pain, the participants will score the intensity of their pain on a visual analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and postoperatively (to be documented before each dose) for the duration of the prescribed medications . Additionally, the study will also seek to track: 1. The total number of pills each patients consume from the prescribed 5 day regimen. 2. Any associated side effects. 3. Additional pain medications prescribed in case of inadequate pain control, postoperatively.
Official Title
Postoperative Pain Management in Rhinoplasty: A Randomized Controlled Trial
Eligibility Criteria
- - Minimum age of 18 years - Able to speak and understand english. - Undergoing rhinoplasty for cosmetic purposes - Undergoing rhinoplasty for treatment of nasal obstruction
- - Less than 18 years of age - Cannot speak and understand english - Patients who have undergone nasal surgery in the past - Patients not undergoing nasal surgery - Women will be excluded if they are either pregnant or lactating as this population does not undergo nasal surgery at our center. - Patients with any known allergies to the class of pain medications used in the study. Please note: Any person interested in this clinical trial should contact the Facial Plastic and Reconstructive Surgery clinic at (650) 736 - FACE (3223) to schedule a consultation with Dr. Sam P. Most to assess their eligibility for the trial. Please note, enrolling in the clinical trial will not entitle the participant to a waiver of charges associated with undergoing nasal surgery.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Cherian K Kandathil, MD
650-721-6000
View on ClinicalTrials.gov